Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
6.40
-0.29 (-4.33%)
At close: Dec 5, 2025, 4:00 PM EST
6.42
+0.02 (0.31%)
After-hours: Dec 5, 2025, 7:41 PM EST

Immuneering Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
41368215128426-
Upgrade
Market Cap Growth
552.40%-68.25%67.99%-69.91%--
Upgrade
Enterprise Value
1902212216267-
Upgrade
Last Close Price
6.402.207.354.8516.17-
Upgrade
PS Ratio
---404.05204.62-
Upgrade
PB Ratio
1.781.652.381.172.73-
Upgrade
P/TBV Ratio
1.871.992.581.252.86-
Upgrade
EV/Sales Ratio
---49.59128.17-
Upgrade
Debt / Equity Ratio
0.020.100.050.040.030.02
Upgrade
Asset Turnover
---0.000.020.09
Upgrade
Quick Ratio
23.844.8210.9213.1026.5316.66
Upgrade
Current Ratio
24.005.2811.3613.5027.0416.73
Upgrade
Return on Equity (ROE)
-43.75%-92.51%-53.36%-38.00%-35.00%-74.56%
Upgrade
Return on Assets (ROA)
-25.91%-51.57%-32.46%-22.38%-20.65%-40.66%
Upgrade
Return on Capital (ROIC)
-27.30%-56.97%-34.81%-23.43%-21.44%-42.85%
Upgrade
Return on Capital Employed (ROCE)
-27.70%-141.70%-61.70%-45.30%-21.00%-47.20%
Upgrade
Earnings Yield
-15.12%-89.35%-24.86%-39.44%-7.88%-
Upgrade
FCF Yield
-12.11%-80.64%-22.92%-35.02%-7.26%-
Upgrade
Buyback Yield / Dilution
-20.43%-5.51%-7.69%-93.84%-175.00%0.00%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q